Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201412129626N4Phase 2Completed
Phase 2, open-label, single-arm trial of human insulin in type 2 diabetes mellitus (T2DM), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Blood glucose level and Insulin level. Started Dec 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201412129626N4.